Related by context. Frequent words. (Click for all words.) 60 BioMarin Genzyme LLC 56 Regulus Therapeutics 55 Eligard R 54 AZASITE 54 1Q FY# 54 regadenoson 53 OLEPTRO TM 53 AnGes 53 Repligen Corporation 53 BioSeek 52 novel antibody therapeutics 52 YTD Fiscal 52 nicotinic alpha 7 52 Qualifying Therapeutic Discovery 52 therapeutic monoclonal antibodies 52 Foundation MMRF 52 3Q FY# 51 Merck Serono division 51 Overall NewMarket 51 Loramyc ® 51 FoldRx 50 Seventh Framework Programme 50 Commercialization Agreement 50 Genaera Corporation 50 4Q FY# 50 TPIAO 50 NV Organon 50 Shigamabs ® 50 Retail Leathercraft 50 Rotarix R 50 Invested assets 50 NIGMS 50 Astex 50 Ps.2 49 drug conjugate ADC 49 Normalized EBITDA 49 Exclusive License 49 BioInvent 49 Captisol 49 Orphan Products 49 Surgical Adhesive 49 EnVivo Pharmaceuticals 49 Therapeutic Discovery Project 49 Etanercept 49 Licensing Agreements 49 SBIR grant 49 DNA RNA Medicines 49 Scancell 49 PATH Malaria Vaccine Initiative 49 Ps.#.# [002] 48 Celladon 48 Non GAAP adjusted EBITDA 48 Panzem R 48 millionin 48 MJFF 48 JPY#.# billion [002] 48 Novexel 48 Applied NeuroSolutions 48 EPSRC 48 LFB Biotechnologies 48 Noninterest expense decreased 48 NIHR 48 NIH Roadmap 48 USD#.#m [001] 48 BioWa 48 Gross Profit Gross 48 elotuzumab 47 Loan originations 47 PsychoGenics 47 Lexicon Genetics 47 Brentuximab vedotin 47 GBP#.#m [003] 47 Tolerx 47 extramural research 47 Merrimack Pharmaceuticals 47 Oxford Nanopore 47 Archemix Corp. 47 EPIAO 47 England HEFCE 47 Chemokine 47 ESBATech 47 -Luiza 47 KNS # 47 Kidney Diseases NIDDK 47 CIMIT 47 Inpharmatica 47 CHF#.# [004] 47 Biomarker Discovery 47 JAK3 47 Virginia Tobacco Indemnification 47 AVEO Pharmaceuticals 47 Innovation CFI 47 Consortium MMRC 47 outlicensing 47 Vandetanib 47 IDRI 47 Development Fund ERDF 47 Genome BC 47 Network HVTN 47 adjusted distributable cash 46 Hybridon